Clinical Laserthermia (Sweden) Insiders
| CLS-B Stock | SEK 4.36 0.12 2.83% |
Clinical Laserthermia employs about 12 people. The company is managed by 7 executives with a total tenure of roughly 28 years, averaging almost 4.0 years of service per executive, having 1.71 employees per reported executive. Breaking down Clinical Laserthermia's management performance can provide insight into the firm performance.
| Rolf Bornschein Insider Chief Officer |
| Mats Ekelund Insider Chief Officer |
Clinical |
Clinical Laserthermia Management Team Effectiveness
The company has return on total asset (ROA) of (0.6625) % which means that it has lost $0.6625 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5892) %, meaning that it generated substantial loss on money invested by shareholders. Clinical Laserthermia's management efficiency ratios could be used to measure how well Clinical Laserthermia manages its routine affairs as well as how well it operates its assets and liabilities.Clinical Laserthermia Workforce Comparison
Clinical Laserthermia Systems is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 138. Clinical Laserthermia holds roughly 12.0 in number of employees claiming about 9% of all equities under Medical Devices industry.
Clinical Laserthermia Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Clinical Laserthermia Price Series Summation is a cross summation of Clinical Laserthermia price series and its benchmark/peer.
Clinical Laserthermia Notable Stakeholders
A Clinical Laserthermia stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Clinical Laserthermia often face trade-offs trying to please all of them. Clinical Laserthermia's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Clinical Laserthermia's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Rolf Bornschein | Chief Officer | Profile | |
| Mats Ekelund | Chief Officer | Profile | |
| LarsErik Eriksson | CoFounder Director | Profile | |
| Stephan MSc | Head Devel | Profile | |
| Karin Peterson | Chief Officer | Profile | |
| Marie MSc | Quality Mang | Profile | |
| Dan Mogren | Chief Officer | Profile |
About Clinical Laserthermia Management Performance
The success or failure of an entity such as Clinical Laserthermia often depends on how effective the management is. Clinical Laserthermia management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Clinical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Clinical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Clinical Laserthermia Systems AB develops and markets therapies, systems, and single-use instruments for thermal treatment of solid cancer tumors in Sweden. Clinical Laserthermia Systems AB has a collaboration agreement with Image Guided Therapy SA to develop and commercialize a software product for MR-generated temperature monitoring and a collaborative license and co-development agreement with MRI Interventions, Inc. to provide navigation and laser ablation platforms for use in spine and neurosurgery. Clinical Laserthermia is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in Clinical Laserthermia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Clinical Laserthermia Systems. Check Clinical Laserthermia's Beneish M Score to see the likelihood of Clinical Laserthermia's management manipulating its earnings.
Clinical Laserthermia Workforce Analysis
Traditionally, organizations such as Clinical Laserthermia use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Clinical Laserthermia within its industry.Clinical Laserthermia Manpower Efficiency
Return on Clinical Laserthermia Manpower
| Revenue Per Employee | 187.1K | |
| Revenue Per Executive | 320.7K | |
| Net Loss Per Employee | 5.3M | |
| Net Loss Per Executive | 9.1M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 2M |
Additional Tools for Clinical Stock Analysis
When running Clinical Laserthermia's price analysis, check to measure Clinical Laserthermia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinical Laserthermia is operating at the current time. Most of Clinical Laserthermia's value examination focuses on studying past and present price action to predict the probability of Clinical Laserthermia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinical Laserthermia's price. Additionally, you may evaluate how the addition of Clinical Laserthermia to your portfolios can decrease your overall portfolio volatility.